Literature DB >> 9160424

Pharmacokinetics of tilmicosin in serum and milk of goats.

A Ramadan1.   

Abstract

Tilmicosin was administered to goats intravenously and subcutaneously to determine its concentration in blood and milk and its kinetic behaviour. After a slow intravenous injection, the serum concentration-time curve indicated a two compartment open model with a mean (SEM) elimination half-life (t1/2 beta S) of 4.36 (0.04) hours. After a subcutaneous injection the drug was eliminated more slowly from serum and milk, with t1/2 beta S of 29.3 and 41.4 hours, respectively. The apparent volume of distribution of tilmicosin was more than 1 litre kg-1. The peak serum tilmicosin concentration was 1.56 micrograms ml-1 6.39 hours after a subcutaneous injection of 10 mg kg-1. Tilmicosin was extensively secreted into milk, reaching a maximum concentration of 11.6 micrograms ml-1 and having a large AUCmilk/AUCserum ratio of approximately 12:1. Tilmicosin was detectable in milk for 11 days after a single subcutaneous dose.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160424     DOI: 10.1016/s0034-5288(97)90179-x

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  10 in total

1.  Pharmacokinetics of tilmicosin (Provitil powder and Pulmotil liquid AC) oral formulations in chickens.

Authors:  E A Abu-Basha; N M Idkaidek; A F Al-Shunnaq
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

2.  The anti-nociceptive potential of tilmicosin against chemical-induced but not thermal-induced pain in mice.

Authors:  A El-Mahmoudy; I Gheith
Journal:  Int J Immunopathol Pharmacol       Date:  2015-10-30       Impact factor: 3.219

3.  Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles.

Authors:  Shuyu Xie; Fenghua Wang; Yan Wang; Luyan Zhu; Zhao Dong; Xiaofang Wang; Xihe Li; Wenzhong Zhou
Journal:  Part Fibre Toxicol       Date:  2011-11-20       Impact factor: 9.400

4.  Modulating Effects of Spirulina platensis against Tilmicosin-Induced Cardiotoxicity in Mice.

Authors:  Abdelaziz E Ibrahim; Mohamed Mohamed Abdel-Daim
Journal:  Cell J       Date:  2015-04-08       Impact factor: 2.479

5.  Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizes.

Authors:  Xiaojin Chen; Ting Wang; Mengmeng Lu; Luyan Zhu; Yan Wang; WenZhong Zhou
Journal:  Int J Nanomedicine       Date:  2014-05-27

6.  Pharmacokinetics of tilmicosin in healthy pigs and in pigs experimentally infected with Haemophilus parasuis.

Authors:  Ling Zhang; Li Zhao; Yonghong Liu; Junfeng Liu; Xianqiang Li
Journal:  J Vet Sci       Date:  2017-12-31       Impact factor: 1.672

Review 7.  Antibacterial Drug Residues in Small Ruminant Edible Tissues and Milk: A Literature Review of Commonly Used Medications in Small Ruminants.

Authors:  Emily D Richards; Krysta L Martin; Catherine E Donnell; Maaike O Clapham; Lisa A Tell
Journal:  Animals (Basel)       Date:  2022-09-28       Impact factor: 3.231

8.  Milk and blood pharmacokinetics of tylosin and tilmicosin following parenteral administrations to cows.

Authors:  Tulay Avci; Muammer Elmas
Journal:  ScientificWorldJournal       Date:  2014-08-06

9.  Evaluation of the antibacterial activity of tilmicosin-SLN against Streptococcus agalactiae: in vitro and in vivo studies.

Authors:  Luyan Zhu; Xiaoxia Cao; Qinxin Xu; Jing Su; Xihe Li; Wenzhong Zhou
Journal:  Int J Nanomedicine       Date:  2018-08-17

10.  Transcriptomic investigation reveals toxic damage due to tilmicosin and potential resistance against tilmicosin in primary chicken myocardial cells.

Authors:  Xiaohui Zhang; Jie Zhu; Bo Yang; Bixia Chen; Jiaxin Wu; Junzhou Sha; Endong Bao
Journal:  Poult Sci       Date:  2020-09-16       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.